Skip to content

The effect of atropine and myopic defocus on choroid.

The effect of atropine and myopic defocus on choroid.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200057225
Enrollment
Unknown
Registered
2022-03-04
Start date
2022-03-08
Completion date
Unknown
Last updated
2023-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Interventions

Group1:DISC and 0.05% atropine eye drops

Sponsors

Eye Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 30 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 30 years; 2. Spherical refractive error of +1.00 to -6.00 D in each eye; 3. Astigmatism of not more than 1.00 D; 4. Best-corrected visual acuity with spectacles of equal or better than 1.0 as Snellen and with soft contact lens of equal or better than 0.8 as Snellen; 5. Healthy eyes, no pathological changes; 6. Able to read, understand and sign informed consent

Exclusion criteria

Exclusion criteria: 1. Intolerant of wearing soft contact lenses; 2. Have used myopia prevention products within 1 year; 3. History of dry eye and other eye diseases; 4. Contraindications to atropine; 5. Intraocular pressure higher than 21mmHg or intraocular pressure difference of more than 5mmHg; 6. Shallow anterior chamber (peripheral anterior chamber depth less than 1/4 corneal thickness)

Design outcomes

Primary

MeasureTime frame
choroidal thickness;

Secondary

MeasureTime frame
choroidal vessel density;Axial Length;Anterior segment;

Countries

China

Contacts

Public ContactJinhua Bao
baojessie@163.com+86 13777762827

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026